Helex

Provider of next-generation gene-editing therapies

placeNew York City, New York, United States calendar_todayFounded 2021 groups22 employees language helex.bio

Registered entities

Innovation

4 patent families — focus: Chemistry & metallurgy; filing pace accelerating. Cited 42 times.

YearFilings
20232
20241
20252
20261

Social engagement

Social engagement: 4.1K social following, 7 posts in the last 12 months — below the industry typical range.

Investor mix

4 investors on record; lead investors include IndieBio, pi Ventures.

Investor typeCountShare
Venture capital375%
Accelerator & incubator125%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

14 Nov 2025 · Veterinary Scientist, Preclinical Research · Telangana

Based on job postings tracked across public sources.

Recent activity

18 Jun 2026
Event
BIO2026
10 May 2026
Event
ASGCT2026
21 Feb 2026
Recognition
Coming soon